Qsymia,Belviq,Approved,for,Obe health Qsymia, Belviq Approved for Obesity, Weight Loss
If the vagina is not offering the firm grip to your male partner, he expresses displeasure in lovemaking. You need to tighten the orifice and regain lost elasticity. You can make use of herbal remedies for loose vagina treatment naturally. H The technology behind listening devices has improved dramatically in recent years, giving new hope to those with impairment. While still far from a perfect replacement for the natural ability to hear, these devices give those with a disabili
The FDA in the past few months has approved two new weight loss drugs for people who struggle with obesity and being overweight Qsymia and Belviq.Both Qsymia (pronounced kyoo-sim-EE-uh and manufactured by Vivus Pharmaceuticals) and Belviq (pronounced bel-VEEK and manufactured by Arena Pharmaceuticals) have been shown to be effective in their clinical trials to help people lose significant amounts of weight.Qsymia is composed of two generic drugs, phentermine (an appetite suppressant) and topiramate (a seizure and migraine medication). Belviq focuses on changing on how serotonin is processed by the brain. Qysmia will be on sale by the end of the year, while Belviq wont be available until sometime in early-to-mid 2013.GM DietShould you consider these drugs if youre obese or seriously overweight?Negative CalorieThe short answer is, yes, if youre obese (BMI 30 or greater) or overweight (BMI 27 or greater) with a weight-related condition such as type 2 diabetes, high blood pressure, or high cholesterol you should consider these drugs.Although likely to be expensive, both weight loss drugs will likely be approved by insurance companies for treatment of obesity or being overweight with other health conditions. Why? Because obesity is a serious chronic health problem affecting more than one-third of U.S. adults (35.7 percent), according to the U.S. Centers for Disease Control and Prevention. As such, it costs insurers a lot of money.
Qsymia,Belviq,Approved,for,Obe